Industry Source Consulting Stock Price, News & Analysis
Company Description
Industry Source Consulting (OTC Link: INSO) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $10.9K.
INSO stock has declined 95.7% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of INSO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Industry Source Consulting (INSO) stock last traded at $0.0001. Over the past 12 months, the stock has lost 95.7%. At a market capitalization of $10.9K, INSO is classified as a micro-cap stock with approximately 109.4M shares outstanding.
Latest News
Industry Source Consulting has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all INSO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
INSO Company Profile & Sector Positioning
Industry Source Consulting (INSO) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing INSO often look at related companies in the same sector, including Item 9 Labs (INLB), Priority Aviat (PJET), Mjardin Group (MJARF), Halo Collective Inc (HCANF), and Avivagen (VIVXF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate INSO's relative position within its industry.